Company: PMVC
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001213900-25-107610
Chunk: 116

Company: PMV Consumer Acquisition Corp.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 8
Chunk 116
---
 be available on acceptable terms, if at all. The current economic environment has made it especially difficult for companies to
obtain such financing. To the extent that additional financing proves to be unavailable when needed to effect a business opportunity,
we would be compelled to either restructure the transaction or abandon that particular business opportunity and seek an alternative business
opportunity. If we are unable to effect a business opportunity, our warrants may expire worthless. In addition, even if we do not need
additional financing to effect a business opportunity, we may require such financing to fund our operations or growth. The failure to
secure additional financing could have a material adverse effect on our continued development or growth. None of our officers, directors
or stockholders is required to provide any financing.

Our
Sponsor controls a substantial interest in us and thus may exert a substantial influence on actions requiring a stockholder vote, potentially
in a manner that you do not support.

Given
that it controls a substantial interest in us, our Sponsor may exert a substantial influence on actions requiring a stockholder vote,
potentially in a manner that you do not support, including amendments to our certificate of incorporation.

Further,
holders of our Founder Shares will be entitled to ten (10) votes for each Founder Share held at any annual or special meeting of stockholders
or in the case of any written consent of stockholders in lieu of a meeting and for all purposes. Holders of our public shares will be
entitled to one vote for each such share. Additionally, only holders of our Founder Shares will have the right to vote on the election
of directors. Holders of our public shares will not be entitled to vote on the election of directors.

We
may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of
at least 50% of the then outstanding public warrants. As a result, the exercise price of your warrants could be increased, the exercise
period could be shortened and the number of shares of our Class A common stock purchasable upon exercise of a warrant could be decreased,
all without your approval.

Our
warrants were issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant
agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure
any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding public